Product Liability – FDA Requires Increase Warning For Yaz Blood Clot Risks
January 12, 2012
Visit msnbc.com for breaking news, world news, and news about the economy
A Food and Drug Administration (FDA) advisory panel voted 21-5 to require drospirenone-containing birth control pills – including Yaz, Yasmin, Ocella, Beyaz, Safyral, and Vestura – to warn about increased risk of blood clots.
via Yaz Side Effects: FDA Requires Increase Warning For Yaz Blood Clot Risks | InjuryBoard Kansas City.
msnbc video: Panel: Benefits of ‘Yaz’ outweigh risks.